Table 3.
Cardiovascular effect of intravenous olprinone and aminophylline in asthmatic patients.
| Time (min) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 30 | 60 | 90 | 120 | 150 | p | anova§ | |
| Systolic blood pressure (mmHg) | ||||||||
| Aminophylline | 130.9 ± 7.1 | 132.6 ± 5.4 | 127.1 ± 5.7 | 125.9 ± 6.3 | 130.4 ± 6.9 | 125.9 ± 5.1 | ||
| Olprinone | 122.4 ± 5.2 | 115.5 ± 5.7 | 113.6 ± 4.1 | 109.4 ± 3.7 | 108.5 ± 4.4 | 116.9 ± 4.8 | 0.2449 | |
| Combination | 129.5 ± 5.0 | 125.0 ± 4.0 | 113.8 ± 4.2 | 114.9 ± 3.1 | 110.5 ± 4.5 | 113.6 ± 4.0 | ||
| Saline | 124.1 ± 2.6 | 123.3 ± 4.7 | 119.1 ± 5.9 | 118.4 ± 3.6 | 118.5 ± 4.5 | 121.5 ± 3.3 | ||
| Diastolic blood pressure (mmHg) | ||||||||
| Aminophylline | 89.5 ± 4.6 | 85.2 ± 4.6 | 85.6 ± 4.9 | 85.2 ± 5.1 | 86.5 ± 5.1 | 83.6 ± 2.9 | ||
| Olprinone | 82.6 ± 4.1 | 73.3 ± 3.2* | 85.6 ± 4.9†† | 67.2 ± 2.9*†† | 63.7 ± 2.6**†† | 63.4 ± 2.9**†† | 0.0174 | |
| Combination | 84.5 ± 3.0 | 78.7 ± 3.0 | 73.6 ± 2.7† | 70.2 ± 2.7*†† | 64.4 ± 3.9*†† | 65.5 ± 2.7**†† | ||
| Saline | 78.5 ± 4.2 | 82.7 ± 5.0 | 77.8 ± 4.7 | 80.5 ± 3.1 | 78.6 ± 3.6 | 80.1 ± 3.9 | ||
| Heart rate (/min) | ||||||||
| Aminophylline | 81.4 ± 2.9 | 74.7 ± 2.4 | 75.5 ± 2.0 | 73.3 ± 2.6 | 71.5 ± 2.4 | 75.7 ± 3.0 | ||
| Olprinone | 83.7 ± 3.4 | 87.9 ± 3.9† | 89.4 ± 4.6*† | 92.9 ± 4.2**†† | 89.2 ± 4.5*†† | 95.4 ± 4.8**†† | 0.0032 | |
| Combination | 79.6 ± 3.0 | 81.5 ± 2.9 | 95.2 ± 3.6**†† | 94.2 ± 3.8**†† | 94.5 ± 4.6**†† | 99.0 ± 5.4**†† | ||
| Saline | 79.7 ± 4.5 | 81.6 ± 5.3 | 76.2 ± 4.1 | 76.0 ± 3.9 | 74.7 ± 3.2 | 76.0 ± 37 | ||
All measurements were expressed as mean ± standard error of the mean (SEM).
Repeated-measure anova was used for differences between four time courses.
P < 0.05
P < 0.01 compared with saline.
p < 0.05
p < 0.01 compared with aminophylline.